AstraZeneca PLC is a multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It focuses on researching, developing, manufa... AstraZeneca PLC is a multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It focuses on researching, developing, manufacturing, and commercializing innovative medicines and vaccines across key therapeutic areas including oncology, biopharmaceuticals, cardiovascular, renal, metabolism, respiratory, immunology, rare diseases, and infection. The company maintains major research and development centers in Cambridge, UK; Gaithersburg, Maryland, US; Gothenburg, Sweden; and Warsaw, Poland, supporting a pipeline that addresses cancer, cardiovascular diseases, kidney diseases, influenza, and other conditions. AstraZeneca PLC delivers products for primary care, specialty care, and global health initiatives, with operations spanning innovative medicines and biologics. Its portfolio emphasizes treatments for respiratory inflammation, autoimmune disorders, gastrointestinal issues, neuroscience, and vaccines, contributing to advancements in non-communicable diseases and access programs in various regions worldwide. Founded in 1999, AstraZeneca PLC plays a significant role in the global biopharmaceutical market through its comprehensive therapeutic focus and strategic R&D investments.
Group Entities data not yet covered for AstraZeneca
We have not yet reviewed AstraZeneca's disclosures for Group Entities data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.
Account Restricted
Your account has been restricted and you no longer have access to paid features.
Contact our support team
or
upgrade your plan
to unblock your account.